Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study

Breast Cancer Research

Volumn 6, Issue 4, 2004, Pages

  Hong, Chi Chen ^a   Tang, Bing Kou ^b   Rao, Venketeshwer ^c   Agarwal, Sanjiv ^c   Martin, Lisa ^a   Tritchler, David ^a   Yaffe, Martin ^d   Boyd, Norman F ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

caffeine metabolic ratio; CYP1A2; malondialdehyde; malondialdehyde deoxyguanosine adducts; mammographic density

Indexed keywords

3 (2' DEOXYRIBOFURANOSYL)PYRIMIDO(1,2 A)PURIN 10(3H) ONE; 3-(2'-DEOXYRIBOFURANOSYL)PYRIMIDO(1,2-A)PURIN-10(3H)-ONE; CYTOCHROME P450 1A2; DEOXYGUANOSINE; DRUG DERIVATIVE; ESTRADIOL; MALONALDEHYDE;

ADULT; ARTICLE; BLOOD; BREAST; BREAST TUMOR; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; ENZYMOLOGY; FEMALE; HUMAN; MAMMOGRAPHY; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTOR; URINE;

ADULT; BREAST; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; CYTOCHROME P-450 CYP1A2; DEOXYGUANOSINE; ESTRADIOL; FEMALE; HUMANS; MALONDIALDEHYDE; MAMMOGRAPHY; MIDDLE AGED; OXIDATIVE STRESS; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS;

EID: 7044272597     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr797     Document Type: Article

References (65)

1. N.F. Boyd G.A. Lockwood J. Byng D.L. Tritchler M. Yaffe Mammographic densities and breast cancer risk Cancer Epidemiol Biomarkers Prev 1998 7 1133 1144 1:STN:280:DyaK1M%2FotFSgsw%3D%3D 9865433
2. G.A. Greendale B.A. Reboussin A. Sie R. Singh L.K. Olson O. Gatewood L.W. Bassett C. Wasilauskas T. Bush E. Barrett-Connor Effects of estrogen and estrogen-progestin on mammographic parenchymal density Ann Intern Med 1999 130 262 269 1:CAS:528:DyaK1MXhsleiu78%3D 10.7326/0003-4819-130-4_Part_1-199902160-00003 10068383
3. J. Brisson B. Brisson G. Coté E. Maunsell S. Bérubé J. Robert Tamoxifen and mammographic breast densities Cancer Epidemiol Biomarkers Prev 2000 9 911 915 1:CAS:528:DC%2BD3cXntFOis78%3D 11008908
4. I.T. Gram G. Ursin D.V. Spicer M.C. Pike Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment Cancer Epidemiol Biomarkers Prev 2001 10 1117 1120 1:CAS:528:DC%2BD3MXptFWqu74%3D 11700258
5. N.F. Boyd P. Connelly J. Byng M. Yaffe H. Draper L. Little D. Jones L.J. Martin G. Lockwood D. Tritchler Plasma lipids, lipoproteins, and mammographic densities Cancer Epidemiol Biomarkers Prev 1995 4 727 733 1:STN:280:DyaK287hsVSnug%3D%3D 8672989
6. N.F. Boyd V. McGuire Evidence of lipid peroxidation in premenopausal women with mammographic dysplasia Cancer Lett 1990 50 31 37 1:STN:280:DyaK3c3htlChtQ%3D%3D 10.1016/0304-3835(90)90175-W 2322925
7. A.K. Basu L.J. Marnett Unequivocal demonstration that malondialdehyde is a mutagen Carcinogenesis 1983 4 331 333 1:CAS:528:DyaL3sXktVWmtLk%3D 10.1093/carcin/4.3.331 6339098
8. C.E. Vaca J. Wilhelm M. Harms-Ringdahl Interaction of lipid peroxidation products with DNA. A review Mutat Res 1988 195 137 149 1:CAS:528:DyaL1cXhs1aksbs%3D 10.1016/0165-1110(88)90022-X 3277035
9. R.H. Burdon D. Alliangana V. Gill Endogenously generated active oxygen species and cellular glutathione levels in relation to BHK-21 cell proliferation Free Radic Res 1994 21 121 133 1:CAS:528:DyaK2cXlsFCiu7c%3D 10.3109/10715769409056564 7981784
10. C.E. Vaca J.L. Fang M. Mutanen L. Valsta 32 P-Postlabelling determination of DNA adducts of malonaldehyde in humans: total white blood cells and breast tissue Carcinogenesis 1995 16 1847 1851 1:CAS:528:DyaK2MXns1Srsr8%3D 10.1093/carcin/16.8.1847 7634413
11. A. Gonenc Y. Ozkan M. Torun B. Simsek Plasma malondialdehyde (MDA) levels in breast and lung cancer patients J Clin Pharm Ther 2001 26 141 144 1:CAS:528:DC%2BD3MXjs12jtbY%3D 10.1046/j.1365-2710.2001.00334.x 11350537
12. H. Yamazaki P.M. Shaw F.P. Guengerich T. Shimada Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes Chem Res Toxicol 1998 11 659 665 1:CAS:528:DyaK1cXjvFars7c%3D 10.1021/tx970217f 9625734
13. The Endogenous Hormones and Breast Cancer Collaborative Group Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 2002 94 606 616 10.1093/jnci/94.8.606
14. K. Ikeya A.K. Jaiswal R.A. Owens J.E. Jones D.W. Nebert S. Kimura Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression Mol Endocrinol 1989 3 1399 408 1:CAS:528:DyaK3cXhsFaku7Y%3D 10.1210/mend-3-9-1399 2575218
15. F.F. Kadlubar M.A. Butler K.R. Kaderlik H.C. Chou N.P. Lang Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis Environ Health Perspect 1992 98 69 74 1:CAS:528:DyaK3sXnsVynsA%3D%3D 10.1289/ehp.929869 1486865 1519630
16. J.D. Yager J.G. Liehr Molecular mechanisms of estrogen carcinogenesis Annu Rev Pharmacol Toxicol 1996 36 203 232 1:CAS:528:DyaK28Xis1ertbw%3D 10.1146/annurev.pa.36.040196.001223 8725388
17. B.T. Zhu A.H. Conney Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res 1998 58 2269 2277 1:CAS:528:DyaK1cXjs12ruro%3D 9622057
18. E.L. Cavalieri E.G. Rogan A unified mechanism in the initiation of cancer Ann N Y Acad Sci 2002 959 341 354 1:CAS:528:DC%2BD38XktFWqu7s%3D 10.1111/j.1749-6632.2002.tb02105.x 11976208
19. N.F. Boyd J. Stone L.J. Martin R. Jong E. Fishell M. Yaffe G. Hammond S. Minkin The association of breast mitogens with mammographic densities Br J Cancer 2002 87 876 882 1:STN:280:DC%2BD38nhsFegsg%3D%3D 10.1038/sj.bjc.6600537 12373602 2376176
20. G. Block F.E. Thompson A.M. Hartman F.A. Larkin K.E. Guire Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period J Am Diet Assoc 1992 92 686 693 1:STN:280:DyaK383pvFyrtA%3D%3D 1607564
21. B.K. Tang D. Kadar L. Qian J. Iriah J. Yip W. Kalow Caffeine as a metabolic probe: validation of its use for acetylator phenotyping Clin Pharmacol Ther 1991 49 648 657 1:CAS:528:DyaK3MXkvVCkurs%3D 10.1038/clpt.1991.82 2060254
22. D.S. Streetman J.S. Bertino Jr A.N. Nafziger Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes Pharmacogenetics 2000 10 187 216 1:CAS:528:DC%2BD3cXjsFartbs%3D 10.1097/00008571-200004000-00001 10803676
23. B.K. Tang Y. Zhou D. Kadar W. Kalow Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements Pharmacogenetics 1994 4 117 124 1:CAS:528:DyaK2MXmsFemtA%3D%3D 10.1097/00008571-199406000-00002 7920691
24. W. Kalow B.K. Tang The use of caffeine for enzyme assays: a critical appraisal Clin Pharmacol Ther 1993 53 503 514 1:CAS:528:DyaK2cXkslKksb8%3D 10.1038/clpt.1993.63 8491061
25. A. Nordmark S. Lundgren S. Cnattingius A. Rane Dietary caffeine as a probe agent for assessment of cytochrome P4501A2 activity in random urine samples Br J Clin Pharmacol 1999 47 397 402 1:CAS:528:DyaK1MXivVCmt7k%3D 10.1046/j.1365-2125.1999.00918.x 10233204 2014237
26. A.D. Kashuba J.S. Bertino Jr G.L. Kearns J.S. Leeder A.W. James R. Gotschall A.N. Nafziger Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping Clin Pharmacol Ther 1998 63 540 551 1:CAS:528:DyaK1cXjvFSlsL4%3D 10.1016/S0009-9236(98)90105-9 9630827
27. G.J. Handelman L. Packer C.E. Cross Destruction of tocopherols, carotenoids, and retinol in human plasma by cigarette smoke Am J Clin Nutr 1996 63 559 565 1:CAS:528:DyaK28Xit1OltLc%3D 8599320
28. R.P. Bird S.S.O. Hung M. Hadley H.H. Draper Determination of malondialdehyde in biological materials by high pressure liquid chromatography Anal Biochem 1983 128 240 244 1:CAS:528:DyaL3sXntVCgtQ%3D%3D 10.1016/0003-2697(83)90371-8 6846796
29. S. Agarwal H.H. Draper Isolation of a malondialdehyde-deoxyguanosine adduct from rat liver DNA Free Radic Biol Med 1992 13 695 699 1:CAS:528:DyaK3sXit1Oqtr8%3D 10.1016/0891-5849(92)90043-G 1459487
30. N.F. Boyd J. Stone L.J. Martin R. Jong E. Fishell M. Yaffe G. Hammond S. Minkin The association of breast mitogens with mammographic densities Br J Cancer 2002 87 876 882 1:STN:280:DC%2BD38nhsFegsg%3D%3D 10.1038/sj.bjc.6600537 12373602 2376176
31. J.W. Byng N.F. Boyd E. Fishell R.A. Jong M.J. Yaffe The quantitative analysis of mammographic densities Phys Med Biol 1994 39 1629 1638 1:STN:280:DC%2BD2crnsFahuw%3D%3D 10.1088/0031-9155/39/10/008 15551535
32. SAS Institute Inc SAS/STAT User's Guide, version 6 1989 Cary, NC SAS Institute Inc
33. I. Ceballos-Picot J.M. Trivier A. Nicole P.M. Sinet M. Thevenin Age-correlated modifications of copper-zinc superoxide dismutase and glutathione-related enzyme activities in human erythrocytes Clin Chem 1992 38 66 70 1:CAS:528:DyaK38Xht1Gmsr4%3D 1733608
34. L.F. Van Gaal A. Zhang M.M. Steijaert I.H. De Leeuw Human obesity: from lipid abnormalities to lipid oxidation Int J Obes Relat Metab Disord 1995 Suppl 3 S21 S26
35. T. Sabuncu H. Vural M. Harma M. Harma Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease Clin Biochem 2001 34 407 413 1:CAS:528:DC%2BD3MXnsFSrsL8%3D 10.1016/S0009-9120(01)00245-4 11522279
36. R. Garg Y. Kumbkarni A. Aljada P. Mohanty H. Ghanim W. Hamouda P. Dandona Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects Hypertension 2000 36 430 435 1:CAS:528:DC%2BD3cXntV2gt7s%3D 10.1161/01.HYP.36.3.430 10988277
37. C.M. Vachon C.C. Kuni K. Anderson V.E. Anderson T.A. Sellers Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States) Cancer Causes Control 2000 11 653 662 1:STN:280:DC%2BD3M7ht1CrtA%3D%3D 10.1023/A:1008926607428 10977110
38. W. Kalow B.K. Tang Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities Clin Pharmacol Ther 1991 50 508 519 1:CAS:528:DyaK38XhslGhug%3D%3D 10.1038/clpt.1991.176 1934864
39. L.S. Aiken S.G. West Multiple Regression: Testing and Interpreting Interactions 1991 Newbury Park Sage Publications Inc
40. K. Vistisen H.E. Poulsen S. Loft Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine Carcinogenesis 1992 13 1561 1568 1:CAS:528:DyaK38Xmt1yiu7Y%3D 10.1093/carcin/13.9.1561 1394840
41. D. Schrenk D. Brockmeier K. Morike K.W. Bock M. Eichelbaum A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers Eur J Clin Pharmacol 1998 53 361 367 1:CAS:528:DyaK1cXlsV2ntA%3D%3D 10.1007/s002280050394 9516038
42. E. Riza I. dos Santos Silva B. De Stavola H.L. Bradlow D.W. Sepkovic D. Linos A. Linos Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women Cancer Epidemiol Biomarkers Prev 2001 10 627 634 1:STN:280:DC%2BD3MzjsVSmsA%3D%3D 11401912
43. P. Muti H.L. Bradlow A. Micheli V. Krogh J.L. Freudenheim H.J. Schünemann M. Stanulla J. Yang D.W. Sepkovic M. Trevisan F. Berrino Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16α-hydroxyestrone ratio in pre- and postmenopausal women Epidemiology 2000 11 635 640 1:STN:280:DC%2BD3crgsV2nsw%3D%3D 10.1097/00001648-200011000-00004 11055622
44. E.N. Meilahn B. De Stavola D.S. Allen I.S. Fentiman H.L. Bradlow D.W. Sepkovic L.H. Kuller Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up Br J Cancer 1998 78 1250 1255 1:CAS:528:DyaK1cXntlSqsb4%3D 10.1038/bjc.1998.663 9820189 2063014
45. M.E. McManus W. Burgess E. Snyderwine I. Stupans Specificity of rabbit cytochrome P-450 isozymes involved in the metabolic activation of the food derived mutagen 2-amino-3-methylimidazo[4,5-f] quinoline Cancer Res 1988 48 4513 4519 1:CAS:528:DyaL1cXlsVCgtLs%3D 3396004
46. Y. Yamazoe M. Abu-Zeid S. Manabe S. Toyama R. Kato Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat liver microsomes and purified cytochrome P-450 Carcinogenesis 1988 9 105 109 1:CAS:528:DyaL1cXktFyls7w%3D 10.1093/carcin/9.1.105 3121205
47. M.A. Butler M. Iwasaki F.P. Guengerich F.F. Kadlubar Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines Proc Natl Acad Sci USA 1989 86 7696 7700 1:CAS:528:DyaK3cXisVSn 10.1073/pnas.86.20.7696 2813353 298137
48. M.A. Butler N.P. Lang J.F. Young N.E. Caporaso P. Vineis R.B. Hayes C.H. Teitel J.P. Massengill M.F. Lawsen F.F. Kadlubar Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites Pharmacogenetics 1992 2 116 127 1:CAS:528:DyaK3sXlsFWlsr0%3D 10.1097/00008571-199206000-00003 1306111
49. I. Tantcheva-Poor M. Zaigler S. Rietbrock U. Fuhr Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test Pharmacogenetics 1999 9 131 144 1:CAS:528:DyaK1MXkvFejsLk%3D 10376760
50. L. Le Marchand A.A. Franke L. Custer L.R. Wilkens R.V. Cooney Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol Pharmacogenetics 1997 7 11 19 1:STN:280:DyaK2s3msVGgsw%3D%3D 10.1097/00008571-199702000-00002 9110357
51. M.A. Kall O. Vang J. Clausen Effects of dietary broccoli on human in vivo drug metabolizing enzymes: evaluation of caffeine, oestrone and chlorzoxazone metabolism Carcinogenesis 1996 17 793 799 1:CAS:528:DyaK28XislCgsbc%3D 10.1093/carcin/17.4.793 8625493
52. E.P. Horn M.A. Tucker G. Lambert D. Silverman D. Zametkin R. Sinha T. Hartge M.T. Landi N.E. Caporaso A study of gender-based cytochrome P4501A2 variability: a possible mechanism for the male excess of bladder cancer Cancer Epidemiol Biomarkers Prev 1995 4 529 533 1:CAS:528:DyaK2MXnsF2mtLw%3D 7549810
53. D.W. Nebert A.L. Roe M.Z. Dieter W.A. Solis Y. Yang T.P. Dalton Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis Biochem Pharmacol 2000 59 65 85 1:CAS:528:DC%2BD3cXhtV2htQ%3D%3D 10.1016/S0006-2952(99)00310-X 10605936
54. H.E. Poulsen S. Loft H. Prieme K. Vistisen J. Lykkesfeldt K. Nyyssonen J.T. Salonen Oxidative DNA damage in vivo: relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion Free Radic Res 1998 29 565 571 1:CAS:528:DyaK1MXhvVWjur4%3D 10.1080/10715769800300601 10098460
55. H. Prieme K. Nyyssonen K. Gronbaek M. Klarlund S. Loft P. Tonnesen J.T. Salonen H.E. Poulsen Randomized controlled smoking cessation study: transient increase in plasma high density lipoprotein but no change in lipoprotein oxidation resistance Scand J Clin Lab Invest 1998 58 11 18 1:STN:280:DyaK1c7nslaqtw%3D%3D 10.1080/00365519850186788 9516652
56. H. Prieme S. Loft M. Klarlund K. Gronbaek P. Tonnesen H.E. Poulsen Effect of smoking cessation on oxidative DNA modification estimated by 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion Carcinogenesis 1998 19 347 351 1:CAS:528:DyaK1cXhs1yku7Y%3D 10.1093/carcin/19.2.347 9498287
57. T. England E. Beatty A. Rehman J. Nourooz-Zadeh P. Pereira J. O'Reilly H. Wiseman C. Geissler B. Halliwell The steady-state levels of oxidative DNA damage and of lipid peroxidation (F2-isoprostanes) are not correlated in healthy human subjects Free Radic Res 2000 32 355 362 1:CAS:528:DC%2BD3cXns1ertr4%3D 10.1080/10715760000300351 10741856
58. G.M. Siu H.H. Draper Metabolism of malonaldehyde in vivo and in vitro Lipids 1982 17 349 355 1:CAS:528:DyaL38Xkt1ahtrc%3D 10.1007/BF02535193 6808279
59. E.A. Jacobson H. Newmark R. Bird W.R. Bruce Increased excretion of malonaldehyde equivalents in the urine after consumption of cooked, stored meats Nutr Rep Int 1983 28 509 517 1:CAS:528:DyaL3sXlvFegs7g%3D
60. C. Lasheras S. Gonzalez J.M. Huerta C. Lombardia R. Ibanez A.M. Patterson S. Fernandez Food habits are associated with lipid peroxidation in an elderly population J Am Diet Assoc 2003 103 1480 1487 10.1016/j.jada.2003.08.023 14576712
61. S.N. Dhanakoti H.H. Draper Response of urinary malondialdehyde to factors that stimulate lipid peroxidation in vivo Lipids 1987 22 643 646 1:CAS:528:DyaL2sXlvFKrurk%3D 10.1007/BF02533942 2823043
62. P.C. Dedon J.P. Plastaras C.A. Rouzer L.J. Marnett Indirect mutagenesis by oxidative DNA damage: formation of the pyrimidopurinone adduct of deoxyguanosine by base propenal Proc Natl Acad Sci USA 1998 95 11113 11116 1:CAS:528:DyaK1cXmt1ajsbg%3D 10.1073/pnas.95.19.11113 9736698 21604
63. B. Halliwell Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept Nutr Rev 1999 57 104 113 1:STN:280:DyaK1M3ksFSgsw%3D%3D 10.1111/j.1753-4887.1999.tb06933.x 10228347
64. S.M. Everett R. Singh C. Leuratti K.L. White P. Neville D. Greenwood L.J. Marnett C.J. Schorah D. Forman D. Shuker A.T. Axon Levels of malondialdehyde-deoxyguanosine in the gastric mucosa: relationship with lipid peroxidation, ascorbic acid, and Helicobacter pylori Cancer Epidemiol Biomarkers Prev 2001 10 369 376 1:CAS:528:DC%2BD3MXjvVaqu7g%3D 11319178
65. C.C. Hong H.J. Thompson C. Jiang G.L. Hammond D. Tritchler M. Yaffe N.F. Boyd Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer Cancer Epidemiol Biomarkers Prev 2003 12 838 847 1:CAS:528:DC%2BD3sXnsValtrg%3D 14504192